Annual ROE
-62.41%
-86.36%-360.58%
December 31, 2023
Summary
- As of February 7, 2025, CTCX annual return on equity is -62.41%, with the most recent change of -86.36% (-360.58%) on December 31, 2023.
- During the last 3 years, CTCX annual ROE has fallen by -84.32% (-384.85%).
- CTCX annual ROE is now -360.58% below its all-time high of 23.95%, reached on December 31, 2022.
Performance
CTCX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-140.54%
-103.16%-275.98%
September 30, 2024
Summary
- As of February 7, 2025, CTCX quarterly return on equity is -140.54%, with the most recent change of -103.16% (-275.98%) on September 30, 2024.
- Over the past year, CTCX quarterly ROE has dropped by -93.77% (-200.49%).
- CTCX quarterly ROE is now -567.53% below its all-time high of 30.06%, reached on March 31, 2023.
Performance
CTCX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CTCX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -360.6% | -200.5% |
| 3 y3 years | -384.9% | -657.3% |
| 5 y5 years | -384.9% | -657.3% |
CTCX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -360.6% | at low | -567.5% | at low |
| 5 y | 5-year | -360.6% | at low | -567.5% | at low |
| alltime | all time | -360.6% | at low | -567.5% | at low |
Carmell Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -140.54%(+276.0%) |
| Jun 2024 | - | -37.38%(+10.9%) |
| Mar 2024 | - | -33.70%(+46.8%) |
| Dec 2023 | -62.41% | -22.95%(-50.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -46.77%(+69.6%) |
| Jun 2023 | - | -27.57%(-191.7%) |
| Mar 2023 | - | 30.06%(+19.2%) |
| Dec 2022 | 23.95%(+9.3%) | 25.22% |
| Dec 2021 | 21.91% | - |
FAQ
- What is Carmell Therapeutics annual return on equity?
- What is the all time high annual ROE for Carmell Therapeutics?
- What is Carmell Therapeutics annual ROE year-on-year change?
- What is Carmell Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly ROE year-on-year change?
What is Carmell Therapeutics annual return on equity?
The current annual ROE of CTCX is -62.41%
What is the all time high annual ROE for Carmell Therapeutics?
Carmell Therapeutics all-time high annual return on equity is 23.95%
What is Carmell Therapeutics annual ROE year-on-year change?
Over the past year, CTCX annual return on equity has changed by -86.36% (-360.58%)
What is Carmell Therapeutics quarterly return on equity?
The current quarterly ROE of CTCX is -140.54%
What is the all time high quarterly ROE for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly return on equity is 30.06%
What is Carmell Therapeutics quarterly ROE year-on-year change?
Over the past year, CTCX quarterly return on equity has changed by -93.77% (-200.49%)